High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$7.9M
$7,873,109
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
OLMA
M
Olema Pharmaceuticals, Inc.
CLARK IAN T
• Director
Equity Compensation
2025-12-19
$1,219,544Largex7
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Director
Equity Compensation
|
2025-12-19 | $1,219,544Largex7 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
CLARK IAN T
• Director
Discretionary SellΔOwn -11.3%
2025-12-19
$7,873,109Whalex3
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Director
Discretionary SellΔOwn -11.3%
|
2025-12-19 | $7,873,109Whalex3 | S | Form 4 |